Low-level Red-light Therapy for Myopia Control in Children
This study is testing a device called Low-level Red Light Therapy Device to see how well it controls myopia (nearsightedness) in children. We are looking for children aged 8 to 13 who have myopia. The study aims to measure changes in axial length (AL), which is the length of the eyeball, at 1 month and 3 months. This device has shown promising results in a Chinese population, and this trial will help confirm its effectiveness in African, Hispanic, and Caucasian children. The study plans to enroll 90 participants.
- Study design
- This is a randomized study comparing Low-level Red Light Therapy Device to wearing single vision spectacles. It plans to enroll 90 participants: 30 Hispanic, 30 African, and 30 Caucasian children.
- What's involved
- If you join, you will either receive the Low-level Red Light Therapy Device treatment twice a day, Monday to Friday, for 3 minutes each time, or wear single vision spectacles. You will have follow-up visits at 1, 3, 6, and 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after enrollment to assess changes in their vision and eye measurements.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Tiffany Chen, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Axial Length (AL) (mm) at Baseline1 month
Axial Length (AL) is characterized as the combination of anterior chamber depth, lens thickness and vitreous chamber depth and measured by results from the IOLMaster. AL will be taken at the 1-, 3-, 6-, and 12-month follow-up visits.
- Axial Length (AL) (mm) at Month 11 month
Axial Length (AL) is characterized as the combination of anterior chamber depth, lens thickness and vitreous chamber depth and measured by results from the IOLMaster. AL will be taken at the 1-, 3-, 6-, and 12-month follow-up visits.
- Axial Length (AL) (mm) at Month 33 months
Axial Length (AL) is characterized as the combination of anterior chamber depth, lens thickness and vitreous chamber depth and measured by results from the IOLMaster. AL will be taken at the 1-, 3-, 6-, and 12-month follow-up visits.
- Axial Length (AL) (mm) at Month 66 months
Axial Length (AL) is characterized as the combination of anterior chamber depth, lens thickness and vitreous chamber depth and measured by results from the IOLMaster. AL will be taken at the 1-, 3-, 6-, and 12-month follow-up visits.
- Axial Length (AL) (mm) at Year 11 Year
Axial Length (AL) is characterized as the combination of anterior chamber depth, lens thickness and vitreous chamber depth and measured by results from the IOLMaster. AL will be taken at the 1-, 3-, 6-, and 12-month follow-up visits.